GKB Ophthalmics is currently trading at Rs. 200.00, up by 0.70 points or 0.35% from its previous closing of Rs. 199.30 on the BSE.
The scrip opened at Rs. 209.20 and has touched a high and low of Rs. 209.20 and Rs. 189.35 respectively. So far 7710 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 209.20 on 11-May-2018 and a 52 week low of Rs. 96.00 on 09-Mar-2018.
Last one week high and low of the scrip stood at Rs. 209.20 and Rs. 168.00 respectively. The current market cap of the company is Rs. 82.45 crore.
The promoters holding in the company stood at 54.08%, while Institutions and Non-Institutions held 0.47% and 45.45% respectively.
GKB Ophthalmics has received an approval to incorporate a new Joint Venture Company between SOMO Vision, South Korea and the company, in which the company will hold 50.01% equity shares. The Board of Directors of the company at their meeting held on May 10, 2018, approved the same.
In order to fund this new Joint Venture and to support future growth of its business and in order to further augment the financial resources of the company, the Board also approved the proposed preferential issues of an aggregate up to Rs 10,07,50,000 fully paid up equity shares at an issue price of Rs 155 ( including a premium of Rs 145) per fully paid up equity shares, for cash consideration.
GKB Ophthalmics is engaged in the manufacture and export of high-quality, single-vision mineral opthalmic lenses.
| Company Name | CMP |
|---|---|
| Poly Medicure | 1862.90 |
| Nureca Ltd. | 281.55 |
| Hemant Surgical Inds | 138.15 |
| Centenial Surgical | 116.50 |
| Prevest Denpro | 446.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
